WebJul 27, 2024 · BIOCON GROUP “We have had a strong start to the year. At a consolidated level, y-o-y revenues grew 23% backed by robust growth in both Biosimilars (29%) and Generics (19%). Core EBITDA grew 25% and margin improved to 31% compared to 30% in Q1FY22. and Net Profit grew 71% to Rs 144 Crore. Our financial performance this … WebBiocon Profit & Loss Report - Get the latest information on Biocon Financial Reports, Profit/Loss stated by Biocon in the past month, quarter, year, on The Economic …
BIOCON SA BALANCE SHEET AS AT March 31, 2024 (All …
WebBIOCON SA STATEMENT OF PROFIT AND LOSS FOR THE PERIOD ENDED March 31, 2024 (All amounts are in US Dollars, except share data and per share data, unless otherwise stated) Note Year ended March 31, 2024 Year ended March 31, 2024 Income Other income 11 1,12,359 3,359 Total income 1,12,359 3,359 ... WebBIOCON PHARMA INC. STATEMENT OF PROFIT AND LOSS FOR THE YEAR ENDED MARCH 31, 2024 (All amounts are in United States Dollars, except share data and per share data, unless otherwise stated) Note Year ended March 31, 2024 Year ended March 31, 2024 Income Revenue from operations 17 59,213,331 54,990,550 lowest online payment solutions fees
Biocon Q3 Results: Firm reports surprise net loss of Rs 41.8 crore ...
Web34 rows · Get Biocon latest Profit & Loss account, Financial Statements and Biocon detailed profit ... WebBiocon, Asia’s largest biotechnology company, started itself with seed capital of Rs.10, 000 in 1978, is now a billion dollar company. The company manufactures … WebFeb 13, 2024 · Shares of Biocon Ltd ended at Rs 234.90, down by Rs 2.80, or 1.18 percent on the BSE. Biotechnology major Biocon on Tuesday reported a net loss of Rs 41.8 crore for the third quarter that ended December 31, 2024. The company reported a one-time loss of Rs 271.4 crore, it said in an exchange filing. jane mccafferty qc